Lakefront Biotherapeutics (LKFT) Shares Outstanding (Diluted) (2013 - 2026)
Lakefront Biotherapeutics' Shares Outstanding (Diluted) was 65.9 million in the quarter ended Jun 30, 2026, unchanged from 65.9 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
From the quarter ended Dec 31, 2013 onward, Lakefront Biotherapeutics has reported Shares Outstanding (Diluted) for 47 quarters.
- Shares Outstanding (Diluted) shows a five-year compound annual growth rate of -0.5% (years ended Dec 2020 to Dec 2025).
- In earlier years, Shares Outstanding (Diluted) was 65.9 million in the year ended Dec 31, 2024 (-0.1%), 65.93 million in the year ended Dec 31, 2023 (+0.4%), 65.7 million in the year ended Dec 31, 2022 (-50.0%) and 131.33 million in the year ended Dec 31, 2021 (+94.4%).
- Quarterly Shares Outstanding (Diluted) has moved between 65.7 million (the quarter ended Dec 31, 2022) and 131.33 million (the quarter ended Sep 30, 2022) over five years.
- Compared with a year earlier, Shares Outstanding (Diluted) was higher in 1 of the last eight quarters, with an average year-over-year change of 0.0%.
- The best year-over-year quarter for Shares Outstanding (Diluted) over five years was the quarter ended Sep 30, 2022 (growth of 94.4%); the worst was the quarter ended Dec 31, 2022 (a decline of 50.0%).
- Per Business Quant data, LKFT's Shares Outstanding (Diluted) in the three quarters before the quarter ended Jun 30, 2026 was 65.9 million (quarter ended Mar 31, 2026), 65.9 million (quarter ended Dec 31, 2025) and 65.9 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Lakefront Biotherapeutics | 1.95 Bn | 1.95 Bn | 3.51 Mn | 65.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.90 Mn |
| Mar 31, 2026 | 65.90 Mn |
| Dec 31, 2025 | 65.90 Mn |
| Sep 30, 2025 | 65.90 Mn |
| Jun 30, 2025 | 65.90 Mn |
| Mar 31, 2025 | 65.90 Mn |
| Dec 31, 2024 | 65.90 Mn |
| Sep 30, 2024 | 65.93 Mn |
| Jun 30, 2024 | 65.93 Mn |
| Mar 31, 2024 | 65.93 Mn |
| Dec 31, 2023 | 65.93 Mn |
| Sep 30, 2023 | 65.70 Mn |
| Jun 30, 2023 | 65.70 Mn |
| Mar 31, 2023 | 65.70 Mn |
| Dec 31, 2022 | 65.70 Mn |
| Sep 30, 2022 | 131.33 Mn |
| Jun 30, 2022 | 131.33 Mn |
| Mar 31, 2022 | 131.33 Mn |
| Dec 31, 2021 | 131.33 Mn |
| Sep 30, 2021 | 67.57 Mn |
API Access
Lakefront Biotherapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();